By decreasing glucagon release, these agonists support the body in maintaining more consistent blood sugar levels, which not only aids in weight loss but also provides overall metabolic benefits
Depending on the patient, a doctor may monitor A1C, fasting glucose, insulin resistance risk, cholesterol, triglycerides, liver enzymes, kidney function, blood pressure, inflammatory markers, thyroid status, and nutrient markers
ONeil PM, Aroda VR, Astrup A, Kushner R, Lau DCW, Wadden TA, et al
Patients should notice a decrease in appetite fairly swiftly, if not immediately, after the first dosage
However, Semaglutide should not be used in combination with other GLP-1 receptor agonists or medications that increase GLP-1 receptor activity